Search
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Fortune 500
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Pfizer
Pfizer
Page 23 of 37
Health
Furious at AstraZeneca, the EU plans export controls for COVID vaccines made on its home turf
By
David Meyer
January 26, 2021
Health
AstraZeneca is finding it hard to keep its COVID-19 vaccine promises
By
David Meyer
January 25, 2021
Health
Good news: COVID-19 vaccine skepticism is waning. Bad news: That might not be enough
By
Bernhard Warner
and
David Meyer
January 22, 2021
Health
WHO reaffirms safety of Pfizer BioNTech vaccine for elderly patients after Norway scare
By
Naomi Kresge
and
Bloomberg
January 22, 2021
Health
Chinese state media attacks BioNTech-Pfizer vaccine, even as China prepares to roll it out
By
Grady McGregor
January 20, 2021
Health
A British hospital network is using blockchain technology to track COVID-19 vaccines
By
Jeremy Kahn
January 19, 2021
Health
No direct link between the COVID vaccine and a recent string of deaths in the elderly, Norway finds
By
Lars Erik Taraldsen
and
Bloomberg
January 18, 2021
Health
As alarm grows over Europe’s dwindling vaccine supplies, Bayer could offer its factories to the cause
By
David Meyer
January 18, 2021
Health
Public health officials warn about slow vaccine rollout as coronavirus variants multiply
By
James Paton
and
Bloomberg
January 18, 2021
Health
The COVID-19 vaccination drive may be slow—but it’s already faster than any in history
By
Jeremy Kahn
January 17, 2021
Health
Sick patients over 80 could be a COVID vaccine risk, Norwegian health officials warn
By
Lars Erik Taraldsen
,
Naomi Kresge
and
Bloomberg
January 15, 2021
Health
Drugmakers hit back at U.K. plan to delay the second dose of COVID vaccines
By
James Paton
and
Bloomberg
January 13, 2021
Health
What we know about which COVID vaccine you’ll receive
By
Sy Mukherjee
January 12, 2021
International
Pfizer and BioNTech’s overlooked third partner will distribute the vaccine in China—and it’s facing some resistance
By
Grady McGregor
January 9, 2021
Health
Pfizer BioNTech vaccine may be effective against fast-spreading COVID-19 variants, study says
By
Jeff Sutherland
,
Jason Gale
and
Bloomberg
January 8, 2021
Most Popular
Innovation
Rivian's CFO hints the end of EV tax credits means manufacturers are being forced to finally make more affordable...
By
Jordyn Grzelewski
and
Tech Brew
Success
Walmart CEO said paying its star managers upwards of $620,000 yearly empowered them to ‘feel like owners’
By
Emma Burleigh
Success
MacKenzie Scott gifts $80 million to Howard University, marking one of the school’s largest donations in its 158-year...
By
Sydney Lake